Gainesville, FL, United States of America

Daniela Carmen Oniciu

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 97(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (2011)
  • Vielle-Toulouse, FR (2011)
  • Gainesville, FL (US) (2007 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniela Carmen Oniciu

Introduction

Daniela Carmen Oniciu is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. Her work focuses on developing compounds that address various health issues, particularly kidney diseases and fibrosis.

Latest Patents

Among her latest patents is the invention of functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof. This invention provides methods for treating or preventing kidney diseases and fibrosis, including chronic kidney disease (CKD), kidney fibrosis, heart fibrosis, uterine fibrosis, and cystic fibrosis. The compounds involved are detailed in various formulae and include pharmaceutically acceptable salts and solvates. Another notable patent is related to salts and esters of APX3330, which includes therapeutic uses for treating diseases such as cancer, liver disorders, ocular disorders, cardiovascular disorders, fibrosis, and inflammatory disorders. This invention also encompasses compositions comprising these compounds and methods for their effective administration.

Career Highlights

Throughout her career, Daniela has worked with notable companies such as Espervita Therapeutics, Inc. and Esperion Therapeutics, Inc. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in treatment methodologies.

Collaborations

Daniela has collaborated with esteemed colleagues, including Jean-Louis Henri Dasseux and Gregory R. Steinberg. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Daniela Carmen Oniciu's contributions to innovation in pharmaceuticals are noteworthy. Her extensive patent portfolio reflects her commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…